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Introduction
We live in an age of incredible technology, discovery and med-
icine. Smartphones, spaceships, and bionic eyes are no longer 
reserved for science fiction. Vaccinations are among the ground-
breaking medical discoveries which “allow us to engage our 
adaptive immune systems to produce highly specific antibodies 
and immunological memory against a potential future infection” 
(Federman, 2014). Through exposure to an inactivated pathogen 
in a safe way, the body’s innate immunity learns how to properly 
adapt to the previously deadly pathogen. Still though, over two 
hundred years following Edward Jenner’s successful use of cow-
pox material to create immunity to smallpox, in 1796, there are 
still those hesitant to make use of vaccinations for themselves 
and their children (Riedel, 2005). Consequently, it is quite con-
cerning that an anti-vaccination movement persists. Particularly, 
people are concerned over a potential correlation between 
vaccinations and autism (Federman, 2014). Is vaccination so 
harmful that it is worth not getting vaccinated? Abstaining can 
put others at a higher risk of developing the given disease be-
cause there will be more disease carriers in the population. Or 
is vaccination harmless, or at minimum,  do the benefits greatly 
outweigh the potential harmful side effects? Further, is it a mat-
ter of science or simply emotion discomforting those against 
vaccinations?
Methods
The research obtained regarding the potential side effects and 
benefits of various vaccinations was collected from a variety 
of sources. Most notably was the use of Touro’s online library 
which provides access to databases such as Pubmed, Proquest, 
and more. Further, additional articles were found through 
Google  Scholar searches of relevant original and peer reviewed 
articles on the topic. After reviewing an adequate number of 
articles on the good and bad of vaccinations, evidence was com-
piled which attempts to answer the research question. 
Potential Benefits of Vaccinations
An important example of an efficacious vaccine is the Smallpox 
vaccination. In fact, the only way to be protected from Smallpox 
is through vaccination. Though Smallpox was once a virulent 
disease taking the lives of over one third of those infected, it has 
since been eradicated by means of vaccinations (Fenner et al., 
1988). The protection from Smallpox, influenza, polio and many 
other diseases and viruses are already well-known vaccination 
benefits. Consequently each specific type of vaccination will not 
be directly expressed in this paper; rather, on the CDC website 
(2015) the entire list of dozens of possible vaccinations can be 
located. Instead, further benefits associated with vaccination 
uptake will be presented. 
Are vaccinations effective at eradicating diseases? Regarding 
the effectiveness to eradicate an epidemic, there is a concept 
known as “herd immunity.” Fine (1993) explains that “If an in-
fection is to persist, each infected individual must, on average, 
transmit that infection to at least one other individual. If this 
does not occur, the infection will disappear progressively from 
the population.” Note, there are those who are too young or 
too sick to become vaccinated, without herd immunity, many 
people will be at risk. Therefore, the higher percentage of those 
vaccinated, the higher the efficacy of any given vaccination in 
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protecting not only those vaccinated, but also the population 
as a whole. 
Are vaccinations worth the expense? Vaccinations are cost ef-
fective and also save considerable amounts of money in health-
care costs. Zhou et al. (2014) determined that for children born 
in the United States in 2009, the nine vaccinations included in 
their study will prevent 20 million cases of disease and save 
42,000 children from early deaths. Further, the same vaccina-
tions will yield a savings of $13.5 billion in direct medical and 
non medical costs, including factors such as treatments for a 
primary infection, travel costs, special education and equipment 
costs for children disabled by disease, as well as further costs 
in extended hospital stays caused by medical complications. 
Furthermore, an additional $68.8 billion will be defrayed in total 
societal costs, most notably lost wages. The net savings would 
total a staggering $82.3 billion.
Though $82.3 billion is no small price, still this study did not 
include the Influenza vaccination, in their estimate. Therefore, 
the determined financial benefits of vaccinations may be un-
derstated. For example, during the eleven influenza epidemics 
in the United States from 1969 until 1994, there were between 
130,000 and170,000 influenza-associated hospitalizations per 
epidemic with more than 20,000 influenza-associated deaths in 
5 of epidemics; and over 40,000 influenza-associated deaths oc-
curred during the other 6 epidemics. (Pleis & Gentleman, 1998). 
Furthermore, this study is limited to the United States, globally 
there exists a more vast market for saving. The additional money 
that is saved in healthcare costs, the further resources  that can 
be allocated for vaccine research. For example, it is believed 
that diseases like cancer, epilepsy, and many more potentially 
can be prevented with vaccines but more research is needed. 
Regardless if these cures are a future possibility, there are plen-
ty other worthy uses for the extra money that can be saved 
through becoming vaccinated. 
Today healthcare workers are able to be protected from their 
sick patients with vaccine preventable viruses. Healthcare work-
ers can be immunized and safely care for sick patients. They need 
protection not only from airborne viruses but also blood borne 
viruses contractible via shared needles. In the United States, it is 
estimated that there are 385 thousand cases of reported needle 
stick injuries per year. Incidentally, this number is an underesti-
mation because it is expected that a  significant number is unre-
ported (Elmiyeh et al., 2004). People need to continue working 
and do not report needle stick injuries because they fear getting 
reprimanded for using equipment improperly.
Another potential benefit of vaccinations is to protect unborn 
children. Mothers who have received vaccinations can protect 
their unborn children from birth defects caused by certain vi-
ruses and further, vaccinated communities can help eradicate 
diseases to benefit future generations. Between 1963 and 1965, 
prior to the licensing of the rubella vaccine in 1969, a global 
rubella outbreak caused the deaths of 11,000 babies, and also 
birth defects in 20,000 babies in the United States. Therefore 
when women are vaccinated as children against rubella, they 
have significantly decreased the chance of passing the virus to 
their unborn or newborn children. This potentially eliminates 
the numerous birth defects associated with rubella, such as 
hearing and or vision loss, heart problems, congenital cataracts, 
liver and spleen damage, and mental disabilities (CDC, 2011). 
These birth defects can decrease quality of life and often require 
resources to help improve outcomes.
The last benefit is that research indicates that some viruses 
cause cancer. For example, the human papilloma virus (HPV) 
has been associated with cervical cancer (Marur et al., 2010). 
Therefore, it is important to realize that vaccinations are im-
portant to immunize against diseases to prevent the onset of 
side effects that can result; some of these may ultimately be 
lifesaving.
Potential Side Effects of Vaccinations
Regarding the possible negatives of vaccinations, it is important 
to consider the evidence for a correlation between vaccinations 
and developing autism. During the late nineties the link dissuad-
ed people from taking vaccinations and now almost twenty 
years later the fear lingers. A clinical study found that “behav-
ioral problems had been linked, either by the parents or by the 
child’s physician, with measles, mumps, and rubella vaccination” 
(Wakefield et al., 1998). This early report became widespread 
and propelled the anti-vaccination movements taking place even 
today. The study was preformed using twelve children ranging 
in ages three to ten, with eleven of them male. Prior tests de-
termined that all twelve children showed satisfactory achieve-
ment of early milestones. These children all lived normal lives, 
but then lost certain skills, notably the ability to communicate. 
Further, they all had gastrointestinal symptoms. e.g. diarrhea and 
abdominal pain. The children underwent assessment and review 
of their gastroenterological, neurological, and developmental 
records. Results indicated all twelve children had intestinal 
abnormalities, ranging from aphthoid ulceration to lymphoid 
nodular hyperplasia. Additionally, “onset of behavioral symptoms 
was associated, by the parents, with measles, mumps, and ru-
bella vaccination in eight of the twelve children with measles 
infection in one child, and otitis media in another” (Wakefield 
et al., 1998). They each developed autistic behavioral disorders, 
nine of which developed autism. Disintegrative psychosis and 
possible post-viral or vaccinial encephalitis were less prevalent, 
representing one and two cases respectively. 
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It is suggested that autistic-spectrum disorders have a direct 
connection to intestinal dysfunction (Wakefield et al., 1998). 
In addition to this study, there are previous studies that link 
the connection between a dysfunctional or inflamed intestine 
and autism. For example, the “opioid excess” theory of autism, 
proposed originally by Panksepp (1979) explains that autistic 
disorders result from “incomplete breakdown and excessive 
absorption of gut-derived peptides from foods, including bar-
ley, rye, oats, and caesin from milk and dairy produce.” These 
remaining peptides can stimulate the formation of harmful 
peptidase enzymes which break down endogenous central-ner-
vous-system opioids, leading to disruption of neuroregulation 
and brain development (Shattock, et al., 1991). Interestingly, 
it has been observed that following removal of a provocative 
enteric antigen, the children achieved symptomatic behavioral 
improvement (Lucarelli, et al., 1995).
Still, the debate around the cause of autism remains controver-
sial, and some, like Wakefield, postulate the incidence is cor-
related with childhood vaccination. To examine this hypothesis 
a retrospective study of 537,303 randomly selected children’s 
cases were examined to determine association of the Measles, 
Mumps, Rubella (MMR) vaccine and autistic disorder. Of the 
group, a total of 440,655 children had received the MMR vac-
cine, with only 758 children diagnosed with some degree on 
the autistic spectrum, of which 316 were diagnosed with the 
most severe on the spectrum, autistic disorder. The incidence 
rate was 0.17% which is insignificant compared to the 7.7% to 
11% range among various unvaccinated groups. Madsen et al, 
(2002) therefore concluded that there is no scientific causation 
between vaccination and autistic disorder or other autistic 
spectrum disorders. 
Regarding the two conflicting studies, the size of their corre-
sponding test groups is incomparable. Wakefield (1998) per-
formed the study on just 12 children in one time frame, while 
Madsen conducted a retrospective study on almost half a mil-
lion vaccinated children over the course of a few years. Though 
Wakefield seemingly proves a correlation between developing 
gastrointestinal problems following an MMR vaccination, more 
research is required to be conclusive that vaccinations can 
cause autism. However, in Madsen’s (2002) study utilized about 
half a million children studied over multiple years. Therefore, 
Madsen’s conclusion can be trusted that autism is not a side 
effect of vaccinations.
In an addendum to reinforce his conclusion, Wakefield added 
another 40 patients to his study, with 39 having the autistic syn-
drome. Still, his total of 52 patients is not as significant as the 
broader study done by Madsen. Another potential issue with 
Wakefield’s study is that he quotes Lucarelli who explains that 
autism is reversible; this is a powerful claim that has yet to be 
confirmed. Furthermore, the Lancet released an official state-
ment retracting Wakefield’s study. Here is their full statement:
Following the judgment of the UK General Medical 
Council’s Fitness to Practice Panel on Jan 28, 2010, it has 
become clear that several elements of the 1998 paper 
by Wakefield et al are incorrect, contrary to the find-
ings of an earlier investigation. In particular, the claims 
in the original paper that children were “consecutively 
referred” and that investigations were “approved” by 
the local ethics committee have been proven to be false. 
Therefore we fully retract this paper from the published 
record (the Editors of the Lancet, 2010).
In spite of this retraction, people clung to this concept that 
there is a relationship between vaccinations and a development 
of autistic spectrum disorders. It is astounding that the very 
Wakefield paper which led people to believe the MMR vaccina-
tion causes autism was retracted due to ethical misconduct.  In 
addition the Lancet retracted the Wakefield paper for nondis-
closure of financial interests. They reported that their sampling 
was randomized, however, in fact, it was selective. For example, 
in order to attract subjects, the researches offered a fee for 
parents of children who received the MMR vaccine and also had 
a previous diagnosis within the autism spectrum.(Sathyanaraya 
Rao & Andrade, 2011).
Not only does Madsen (2002) amply prove there is no correla-
tion between vaccinations and autistic disorders, Wakefield’s 
study has since been completely retracted. Perhaps the most 
appalling long-term affect is that the myth is so deeply ingrained 
that parents are refusing to vaccinate their kids out of fear of 
harm, and, unfortunately, some of these kids will or have already 
succumbed to the greater danger of contracting a vaccine-pre-
ventable illness. Because the official retraction was a mere para-
graph in length and lacks detailed explanations, it slipped under 
the radar of the common folk and now people still believe 
Wakefield has legitimacy. 
There is a potentially serious complication from vaccine admin-
istration known as Guillain–Barré Syndrome (GBS), which is a 
paralysis that begins on the lower extremities and migrates up 
the body. The legs become numb and as it ascends the body it 
leaves paralysis of muscles in its wake. An immune response is 
triggered that directly destroys either the myelin sheath sur-
rounding the peripheral nerves or even the axon itself, leaving 
scar tissue in its midst. Unfortunately, if not promptly treated 
it will paralyze the breathing center, which is located at C3 of 
the cervical spinal column and breathing will require mechani-
cal assistance (Koski, 1994). Dr. Tamar Lasky and her colleagues 
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studied the 1992-1993 Influenza Seasons and did in fact discover 
a direct increase in cases of Guillain–Barré Syndrome within the 
first six weeks following vaccination. At first glance, this discov-
ery should shy people away from getting vaccinated. However, 
Lasky determined the increased risk to be only an additional 
0.61 cases per million vaccinations. Further, even after an ad-
justment to include four factors that would make the original 
estimate conservative, their most accurate estimate of the at-
tributable risk would be 1.1 case per every million vaccinations. 
Therefore Lasky argues that, “Even if Guillain–Barré syndrome 
were a true side effect in subsequent years, the estimated risk 
for Guillain–Barré syndrome of 1 to 2 cases per million persons 
vaccinated is substantially less than that for severe influenza, 
which could be prevented by vaccination in all age groups, espe-
cially persons aged ≥65 years and those who have medical indi-
cations for influenza vaccination” (Lasky et al., 1998). Therefore, 
despite the reality of the GBS complication caused by vaccina-
tions, many still opt to prevent serious diseases by vaccination. 
Although avoiding vaccinations still remains controversial to 
many, the relative risk of experiencing a complication is low, and 
it could be considered neglect by parents to abstain from vac-
cination of children in an era where vaccines can protect these 
children from many serious diseases. As was aforementioned in 
this paper,  the disproportionate number of 20,000 lives that 
would be saved from influenza epidemics alone far outweighs 
the minimal risk of contracting GBS (Pleis & Gentleman, 1988). 
Each year there are 30,000 Vaccine Associated Events (VAE)s 
reported, with 13% comprising disability, hospitalization, serious 
illness, or death. While most of the reactions were classified as 
mild involving fever, irritability, or local reactions such as mild 
redness at the site of the injection that is sometimes caused by 
the preservative thimerosal or other innocuous inflammatory 
response (Vaers.hhs.gov, 2015). Even with the reporting system, 
many events are thought to occur by coincidence, as other syn-
dromes such as Sudden Infant Death Syndrome (SIDS) occurs 
without any etiological basis (Vaers.hhs.gov, 2015). As Hardt et. 
al. (2013) point out, vaccine associated disease incidence is re-
duced in populations to the point of inability to remember what 
these diseases are and how they can harm. This phenomenon 
may cause vaccine adverse reactions to loom as predominant 
errs in how we provide healthcare and disproportionately 
place fear of harm above disease prevention in the minds of 
well-meaning caregivers.  
An additional potential side effect from vaccinations can stem 
from the actual vaccinations. As was explained, a vaccination is 
effective through exposure to inactivated harmless pathogens. 
In some cases, though, the pathogen can potentially become 
harmful in the future. An example is varicella, commonly known 
as chickenpox, a vaccine-preventable illness which is a very 
common and usually benign childhood disease. Chickenpox 
however can cause serious painful complications in those who 
contract the illness in adulthood, in the form of Zoster, com-
monly known as shingles. The vaccine immunity wanes as one 
ages, and the dormant virus introduced with the vaccination can 
strike. As the body’s ability to mount an immune response de-
clines, the people will be more dependent on re-administering 
of the given vaccine (Shuette & Hethcote, 1999). This side effect 
may scare off potential patients, though in light of this potential 
side effect, maybe it is in fact more beneficial to withhold from 
the chicken pox vaccination. Though, a simple solution would 
be to receive a new vaccination every number of years. Further, 
Shuette and Hethcote (1999) discovered that even when those 
vaccinated for Chickenpox develop Shingles as adults, the symp-
toms are milder, since they still have some immunity,  compared 
to those never vaccinated. Even if chicken pox vaccinations have 
a reason to be withheld, this side effect is not a reason to refrain 
from other types of vaccinations, such as Polio, Smallpox or the 
MMR vaccinations. 
Discussion
In conclusion, research has not been able to produce a correla-
tion between autism spectrum disorder and vaccination. Still, 
it is important to acknowledge the presence of fears, distrust, 
and other reasons to oppose vaccines. Although the adverse 
reactions are minimal, to the person who suffers an adverse 
event that is one too many.  The Food and Drug Administration 
(FDA), Centers for Disease Control and Prevention (CDC) 
and American Academy of Pediatrics (AAP) all support vac-
cine administration, and have successfully reduced prevalence 
of vaccine preventable diseases. However, we must ensure that 
appropriate education is disseminated to caregivers of children 
to protect the safety and lives of others by supporting vaccine 
administration so people with inability to receive vaccines will 
be better protected against vaccine preventable diseases. By en-
suring a robust vaccination program, and supporting the expan-
sion of research on vaccine preventable diseases, we can help 
develop vaccines for illnesses and diseases that currently remain 
untreatable. Perhaps new vaccine research might dispel vaccine 
myths which will increase the rates of vaccination, protecting 
more of the population.
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